| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 0.1 | 0.0 |
| Gross profit | 0.0 | 0.0 |
| Net income | -0.9 | -8.4 |
| EPS (diluted, $ a share) | $-0.13 | $-3.06 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +67.5% |
|---|---|
| Gross margin | 46.2% |
Source
Read the filing ↗
10-Q filed with the SEC, NASDAQ: HIND. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Vyome Holdings, Inc: key numbers
- Share price
- $1.53Close, Nov 16
- Market cap
- $10.7M
- Shares outstanding
- 7.02MLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Pharmaceutical PreparationsSIC 2834
Today's reference numbers, updated daily. Not a valuation or a recommendation.